Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117229) titled 'A Multicenter, Observational Study of Crisugabalin in the Real-World Treatment of Patients with Paresthesia Caused by Diabetic Distal Symmetric Polyneuropathy' on Jan. 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Guangdong Provincial Hospital of Chinese Medicine
Condition:
Paresthesia Caused by Diabetic Distal Symmetric Polyneuropathy
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-01
Target Sample Size: Crisugabalin:138;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307048
Disclaimer...